Therapeutic options for the severely hypertriglyceridaemic patient: Now and in the future
Dr Pamela Bowe MorrisWatch the presentation >
ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia
(ii) Olezarsen
Professor Sam Tsimikas
Watch the presentation >
ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia
(i) Plozasiran
Professor Daniel Gaudet
Watch the presentation >
Molecular insights into lipolysis
Dr Michael PlougWatch the presentation >
Genetics of familial chylomicronaemia syndrome (FCS) and severe hypertriglyceridaemia
Professor Robert A HegeleWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.